chrisvoncsefalvay/vaers-outcomes huggingface dataset:
A nurse reported the occurrence of an injection site reaction in a 5 year old male who was vaccinated with Infanrix for prophylaxis. The reporter submitted a report directly to VAERS. The subject had no relevant medical history, concurrent conditions or concurrent medications. On 8/15/02, the subject received his fourth injection of Infanrix (553A2) into the left leg. Subsequently, the subject developed an injection site reaction characterized by swelling and redness. The reporter stated that the injection site was related to Infanrix administration. The injection site reaction resolved. This case has been linked to report A0381019A and a0381144 due to same reporter.
felt dizzy; had a headache; felt tired; have pain in my arm where i got the injection; Yawning; Joint pain; Achy/ liitle pain; Still feel bad/not just feeling good; legs hurt; This is a spontaneous report from a contactable consumer (patient) via Pfizer. A 54-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: ER8732, Expiry date: Jul2021), via an unspecified route of administration in the left arm on 26Mar2021 (at the age of 53-years-old) as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Patient received his 1st dose on Friday 26MAR2021, and Friday he was ok, but when he got home and all weekend he felt dizzy, had a headache, felt tired, and have pain in his arm where he got the injection. He had been tired and achy all over and he got a little pain. Patient further explained that, when he first got it on 26th, he felt okay. They let him sit down for few minutes, about 20 minutes then he just came home and he was just so like achy, tired dizzy, headache and he was yawning. He was still tired, achy, dizzy, his joints were, everything. He was not just feeling good. His legs hurt and he still felt bad. Patient stated he was still dizzy, he still had little headache and tired. Patient second dose was scheduled on 16Apr2021, 12:00. The clinical outcome for the events was not recovered except unknown for legs hurt and have pain in my arm where i got the injection.  No follow-up attempts are needed. No further information is expected.
Light Headedness; Pain was over back of his eye sockets to around the temples and the top of his head; Mild headaches; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Light Headedness), EYE PAIN (Pain was over back of his eye sockets to around the temples and the top of his head) and HEADACHE (Mild headaches) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004M20A and 032L20A) for COVID-19 vaccination.     The patient's past medical history included Hyperlipidaemia and Anxiety. Concurrent medical conditions included Hypertension. Concomitant products included IRBESARTAN (AVAPRO), ATORVASTATIN CALCIUM (LIPITOR) and ESCITALOPRAM OXALATE (LEXAPRO) for an unknown indication.   On 19-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced DIZZINESS (Light Headedness), EYE PAIN (Pain was over back of his eye sockets to around the temples and the top of his head) and HEADACHE (Mild headaches). At the time of the report, DIZZINESS (Light Headedness), EYE PAIN (Pain was over back of his eye sockets to around the temples and the top of his head) and HEADACHE (Mild headaches) outcome was unknown.
Blocked/Muffled Hearing in Right Ear.  Increasingly-Constant Ringing in Ear.
This spontaneous report as received from a patient (a pharmacist) via a company representative refers to a male patient of unknown age. On an unknown date in November 2014 the patient was vaccinated with ZOSTAVAX (0.65 ml dose, route and lot # not reported). No concomitant therapy was reported. On an unknown date in November 2014, within 48 hours after receiving ZOSTAVAX, the patient developed headache that lasted 24 hours. And within 7 to 10 days of receiving ZOSTAVAX vaccine, the patient had a large rash at the injection site on his left arm that developed into a knot. That had since healed on an unspecified date, approximately in 2014 (also reported as recovered after 7-10 days). There was no treatment given for the events and the patient did not seek medical attention. The relatedness between the events and ZOSTAVAX was not reported. Additional information has been requested.
Left arm lymph node swollen in armpit, fever-low grade temp-99 degrees-100 degrees chills. Dr. put patient on LEVAQUIN 500mg every day for 10 days.
CMA accidentally administered Pfizer as second dose in COVID vaccine series when patient received Moderna as first dose.  First dose of Moderna vaccine administered on 7/23/22
Lesions noted 2 days post vaccine.  Lesions noted on both right and left arm right and left flanks.  Superior to iliac crest and medial to the frontal plane.  Also noted slightly superior to ankles.
6 days after shot bruising formed (yellow green) then covid arm began.  Covid arm lasted 3 days. Second shot taken February 27th. Covid arm reappeared 2 days after immunization.
This spontaneous report as received from a Licensed Practical Nurse refers to 4 unspecified patients of unknown age and gender. On an unknown dates the patients were vaccinated with PROQUAD (Merck) 0.5 ml, subcutaneous (lot # not reported). On an unknown dates the patients received doses of PROQUAD (Merck) which had undergone a supported temperature excursion. No adverse experiences were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Six days following the vaccine, I noticed a rash appear near the injection site. The rash started our spotty but became solid. The rash lastly about four days. It was extremely itchy and warm to the touch. I also felt nauseous while the rash was present. When the rash went away, I experienced chest pain for a few days.
Rash on arms be legs  had to go to the ER MD sad reaction to ,2 shot taken by EMS to  hosp STEMI
This spontaneous prospective pregnancy case was reported by a nurse and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (18 weeks pregnant) in a female patient of an unknown age (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma, Psoriasis, Anxiety, Depression and Drug allergy (Patient reported drug allergy to quinolones.). Concomitant products included LORATADINE (CLARITINE) and MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication.    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 04-Jun-2021. On 30-Dec-2020, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (18 weeks pregnant). On 30-Dec-2020, MATERNAL EXPOSURE DURING PREGNANCY (18 weeks pregnant) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   There was no treatment medication reported.  The patient's had one previous pregnancy which was a live full term birth Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
This spontaneous report as received from a physician refers to a patient of unknown age and gender. No concurrent conditions, medical history, allergy/drug reactions and concomitant medications were reported. On 08-JUL-2017, the patient was vaccinated with improperly stored dose of GARDASIL 9 lot # M044717, expiry date: 19-JUL-2019, 1 dose (route, anatomical location were unknown) for prophylaxis. It was reported that the vaccine was exposed to a temperature range of 32F to 35F for a duration of 35 minutes and 47F to 77F for a duration of 29 minutes. There was no previous temperature excursion. Data logger was involved. No adverse effects were reported. There were no product quality complaints (PQC) involved. This is one of the two reports from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1707USA006790.
After 2-2.5 hrs vaccine was given, pt developed swollen tongue and bloodshot eyes. Pt went to urgent care afterward and admitted to ER for 2 nights.
530pm shot time by 1pm the next day I was very tired feeling nauseous, then the head ache started, skin burning,  all over body pain,  sweating,  shaking,  freezing,  fever.
Broke out in hives; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received unknown dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Lot number was not reported) as SINGLE DOSE for COVID-19 immunization. The patient's medical history and concomitant medications were not reported.  The patient reported that she broke out in hives on an unspecified date and asked whether this was side effect. The outcome was unknown for the reported event.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
This spontaneous report was received from a consumer regarding himself, an 87 year old male patient with a pertinent medical history of weak legs, arthritis, bursitis and carpal tunnel. The patient's medical history included a case of shingles on the forehead on unspecified dates in 1992 and the patient still experiences pain when cold air comes in contact with that spot on his forehead. On 25-NOV-2013 the patient was vaccinated with ZOSTAVAX and an unspecified pneumococcal vaccine. Dosages and routes of administration were not reported. Concomitant therapy included SPIRIVA. On 02-DEC-2013 (reported as "about a week after vaccination") the patient experienced itching on his feet that traveled up his legs to above the knee. The itching was worse at night. The patient called the physician's office and spoke with a nurse. Treatment included an unspecified topical hydrocortisone cream which helped reduce the itching. The outcome was reported as recovering/resolving. No causality assessment was provided. Additional information has been requested.
Patient left pharmacy premises immediately after vaccination, against the advice of the myself the vaccinating pharmacist. Patient reported that maybe 10 min after leaving, while driving home, he experienced chest tightness (shortness of breath) and felt faint. He pulled over and called 911, he was taken to the hospital and was discharged 2/6/15. Patient did not recall names of medications he was treated with at the hospital. He came to the pharmacy 2/7/15 to inform us of the event and to fill some prescriptions given to him at discharge.
This spontaneous report as received from a healthcare worker refers to a 14 year old female patient. The healthcare worker reported that on an unknown date the patient was vaccinated with GARDASIL (lot # and expiration date unspecified) (dose, route and anatomical location unspecified). The reporter said that on an unknown date the patient was administered GARDASIL and fainted. At the time of the report the outcome of faint was unknown. Additional information is not expected.
Severe chest pain; fever; This is a spontaneous report from a contactable consumer (patient). A 15-year-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EW0179), via an unspecified route of administration in the right arm on 03Jun2021 at 10:00 (at the age of 15-year-old) as single dose for COVID-19 immunisation in public health clinic. Medical history included Tourette's syndrome from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included pimozide taken for an unspecified indication, start and stop date were not reported. The patient previously received first dose of bnt162b2 (Lot number: EW0179), via an unspecified route of administration in the right arm on 13May2021 at 12:15 (at the age of 15-year-old) as single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 03Jun2021 at 22:00, the patient experienced severe chest pain and two days of fever up to 39.8 degree Celsius. The events were reported as non-serious. The patient did not receive any treatment for the events. The patient underwent lab tests and procedures which included fever: 39.8 centigrade on 03Jun2021. Since the vaccination, the patient had not been tested for COVID-19. The outcome of severe chest pain was resolved on an unknown date in Jun2021, and fever was resolved on 05Jun2021.
Night of 2nd injection of Moderna shot, developed headache, fever, chills, muscle aches, joint aches and nausea. Day after injection, fatigue, continued headache and joint pain.  2 days after injection continued joint pain. 3 days after injection, started developing raised red bumps on right hand.  6 days after injection, right hand continues having itchy bumps and also started developing itchy, raised bumps on left side of abdomen.  9 days after injection, raised, itchy bumps/rash on right hand, upper left torso and now rash moves down abdomen and starts developing on chest and neck. 13 days after injection, right hand bumps become more prominant and raised and itchy; itchy, raised bumps start developing on left hand, left front abdominal area full rash, while right abdominal area has raised itchy bumps but in fewer number than left side of front torso, chest and neck continue to have raised, itchy bumps, left and right side of face develops raised and itchy rash, in ears as well.  Day 13 visited the doctors office who suggested contacting CDC and filling out VAERS form. Signs/symptoms seem to only be skin rash.
Flu shot on Wed afternoon - Arm little sore am of next day. But worse as days went on. Kept her up during the night. Took Tylenol about 7pm (Thurs) states can't raise arm. Took more Tylenol at 11pm. Elevated in chair with ice pack 2 more Tylenol At 2am and more at 530 am. Had to have husband help her dress. Spoke to her on 11/16/07. States that it went away the next day and she is ok. She did not contact Dr. (family).
Chills started 2015 pm 3/ 10.  Fever 99.6 10: 30 .Aches and pains ,feeling bad 10:30pm. Continued thru night and next day. Temp 100.0 11: am 3/ 11 gave Dayquil. Still feeling bad all over. 3/12. Fever of 99.3 continuing, taking Tylenol for fever. No appetite.
Complete injection arm paralysis starting the evening of administration 03/12/18. Arm had improving and worsening pain and paralysis for a week after immunization. Patient then went to emergency room to be treated the following Monday. Today 3/21/18 she claims that the arm is improving and she is starting to feel better.
12/18/20 08:00PM Mild headache;  12/19/20 headache resolved; chills, loose bowel movement, fatigue. 12/20/20  loose bowel movement, rash on back and disappeared face red lips swollen. 12/21/20 symptoms continued medications taken Benadryl.  Imodium; rash resolved and loose bowel movements later in the day. Abd discomfort, pain and nausea present since vaccine given.
1 of 2 children who devel localized rxn @ HBOC inj site; pt devel erythema & swelling @ HBOC inj site; A knot the size of a quarter was also present; no tx; pt recovered;
Called to patient room because he fell after receiving the HPV shot.  By report, he received the shot, band aid was placed, then he leaned against the medical assistant, and then fell slowly to the floor, hitting the front part of his face.  I was called immediately to the room.  When I got there patient was on the floor being held by mom and my medical assistant.  He was coming to, but was confused.  Initially his fists were clenched, but then relaxed after a few seconds.  He wasn't sure what happened and the last thing he remembered was getting the shot.  He had some blood in his mouth, and he said he pee'd on himself.  He rinsed out his mouth with minimal bleeding.  The source of the bleeding couldn't be identified, but there was no further bleeding.  At first his right forehead was hurting, but that resolved.  He complained of anterior neck pain and feeling like his skin was stinging.    O: BP 110/62, Gen:  Alert and oriented.  Initially was pale, but improved with time.   OP:  No visible bleeding, OP clear Eyes:  EOMI.  Small bruise below right eye that was from previous injury Neck:  No posterior/cervical neck pain or tenderness. He had full range of motion in his neck, with tenderness felt in anterior neck and chest  when he extended his neck.  Neuro:  Nonfocal.    Patient was monitored for 30 minutes after the event.  He had no recurrence of LOC and left the clinic in good condition.
Tenderness at site for first three days, then symptoms resolved. Day 7 after vaccine, arm tenderness, aching, itching.
Pt stated he started feeling bad that night, next day voice went scratchy and low still has scratchy voice after 1 month. Had low grad fever for 2-3 days, chills, muscle aches in arms/legs. No energy - even after 1 month.
Patient received an expired vaccine as a 1st dose; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received an expired vaccine as a 1st dose) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received an expired vaccine as a 1st dose). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received an expired vaccine as a 1st dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. Treatment information was not provided by the reporter.
This spontaneous report was received from a registered nurse refers to unspecified number of patients of an unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On an unknown date unspecified number of patients were vaccinated with improperly stored PNEUMOVAX23 (Lot #, dosage regimen were not reported). No adverse effects were noted. This is one of the several reports received from same reporter. Additional information has been requested.
63 year old female non immunocompromised received Zostavax Immunization on 9/28/06, on 10/01/06 developed diffuse hepatic lesions on body. Mild erythema and warm over injection site.
(L) arm with mod erythema 10.1 cm x 7.5 cm in deltoid area with mild swelling
Participant became nauseated and blood pressure increased 147/96 "stated eggs cause her to be nauseated".
Severe body aches, chills, headache. I was physically unable to get out of bed due to body aches.
MODERNA use for COVID-19 under Emergency Use Authorization (EUA):patient suffered DVT 1 day after receiving Moderna COVID booster injection. patient started on Apixaban for treatment of DVT.
About two weeks after receiving the first dose, I started to get sharp pains around the temple of my left eye. I would get headaches to the point that I would take medication. I called my doctor and they sent me to Advent Health ER where they performed a CT scan. They didn't see anything abnormal and gave me two prescriptions to assist with nausea and headaches. I was given Butalbital-Acetaminophen-Caffeine and Metoclopramide as needed.
This spontaneous case was reported by a pharmacist and describes the occurrence of in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The patient's past medical history included Shingles (About 10-12 days after receiving the vaccine, her shingles reactivated and she got the shingles infection. She originally had shingles when she was 32 years old.). On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Not Provided; The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant product used was unknown. Treatment information was not provided. Reporter did not allow further contact; Most recent FOLLOW-UP information incorporated above includes: On 19-Apr-2021: Patient demographics were updated. The reporter stated the patient is not themselves. The patient is an unknown patient with unknown details and no way to contact them.
We gave the Moderna Covid-19 vaccine to someone that's 17yrs old; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (We gave the Moderna Covid-19 vaccine to someone that's 17yrs old) in a 17-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (We gave the Moderna Covid-19 vaccine to someone that's 17yrs old). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (We gave the Moderna Covid-19 vaccine to someone that's 17yrs old) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant and treatment details were provided.
Severe pain in left arm at point of shot. Hurt for days after with swelling, pain and redness. Since then, I have had weakness and pain in the arm and will be woken up at night with the same severe pain in the area and swelling.
fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue) in an 89-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced FATIGUE (fatigue). At the time of the report, FATIGUE (fatigue) outcome was unknown. Not Provided          No concomitant medication was reported.  No treatment information was provided.
7/25/03: given 1st dose Varivax. Beginning 7/28/03 had pleuritic chest pain, neck pain, right arm pain, with wrist and fingers int. stiffness (no swelling). Fevers 102 degrees, chills, sweats, ulcers on palatine arches, tongue, lip, gingiva.